News-Medical.Net October 28, 2024
A recent study published in PNAS explores the potential benefits of expanding access to novel weight loss drugs to enhance survival rates in overweight and obese individuals.
The threat of obesity
Obesity affects 42% of adults in the United States, with those between 40 and 59 years of age most likely to be affected by this condition.
Obesity increases the risk of several chronic diseases, including cancer, type 2 diabetes mellitus (T2DM), and cardiovascular disease (CVD). This disease also exacerbates infectious conditions, including influenza and coronavirus disease 2019 (COVID-19), and increases the risk of post-surgical and hospital-acquired infections.
Obesity prevalence and related healthcare costs are higher among those with lower socioeconomic status and inadequate insurance coverage. In fact, obese adults...
Today's Sponsors
Today's Sponsor